Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01811446 · ClinicalTrials.gov registry record · NA

Evaluation of Muscle Activation Efficiency in Challenging Subjects

A NA study of Obesity and COPD, sponsored by Niveus Medical.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT01811446 is a NA study of Obesity and COPD that has completed, run by Niveus Medical. The registered enrollment target is 30 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01811446, a NA study of Obesity and COPD, has completed, sponsored by Niveus Medical.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether muscle activation can be accomplished more effectively and comfortably in challenging subjects using novel configurations of an activation device. A novel device will be compared side by side with a market leading device.

Conditions Studied

Interventions

  • DEVICE Muscle Activation with Niveus and Intelect Devices

Study Locations (1)

California

  • Fogarty Clinical Research - Mountain View

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2013-03
Phase NA

Sponsor

Niveus Medical

2 total trials

What the Registry Record Tells You About NCT01811446

The ClinicalTrials.gov registry entry for NCT01811446 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (96% lower). The listed sponsor is Niveus Medical, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 1 intervention - of which Muscle Activation with Niveus and Intelect Devices is the first listed.

NCT01811446 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01811446 about?

NCT01811446 is a clinical study titled "Evaluation of Muscle Activation Efficiency in Challenging Subjects". The purpose of this study is to determine whether muscle activation can be accomplished more effectively and comfortably in challenging subjects using novel configurations of an activation device. A novel device will be compared side by side with a market leading device.

What is the current status of trial NCT01811446?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2013-03.

What conditions does trial NCT01811446 study?

This clinical trial studies the following conditions: Obesity, COPD.

What interventions are being tested in trial NCT01811446?

The interventions under investigation include: Muscle Activation with Niveus and Intelect Devices (DEVICE).

Who is sponsoring clinical trial NCT01811446?

This trial is sponsored by Niveus Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01811446 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.